logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
I

Inna Y. Gong

Princess Margaret Cancer Centre
H指数:21
被引数:2,222

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic tumor volume trajectory during bridging and association with outcomes after CAR T infusion in large B-cell lymphoma

桥接治疗期间大B细胞淋巴瘤的代谢肿瘤体积变化轨迹及其与CAR T输注后结局的关联

Bone Marrow Transplantation
IF5.2
2026-11-090
PRE
Inna Y. Gong; Seyed Ali Mirshahvalad; Esraa Almutairi; Mahmood Aminilari; Meenakshi Jeeva; Massimiliano Marinoni; Maria Azab; Anca Prica; Danielle Rodin; Sita Bhella; Tomohiro Aoki; Christine Chen; Robert Kridel; Vishal Kukreti; Abi Vijenthira; Chloe Yang; Badr Id Said; Woodrow Wells; Ur Metser; Michael Crump; David Hodgson; Patrick Veit-Haibach; John Kuruvilla
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T

桥接疗法在复发/难治性大B细胞淋巴瘤患者接受第三代CAR T治疗中的效果

Hematological Oncology
IF3.9
2026-03-030
PRE
Inna Y. Gong; Meenakshi Jeeva; Katrina Hueniken; Mahmood Aminilari; Massimiliano Marinoni; Anca Prica; Danielle Rodin; Sita Bhella; Tomohiro Aoki; Maria Azab; Christine Chen; Robert Kridel; Vishal Kukreti; Abi Vijenthira; Chloe Yang; Nauman Malik; Woodrow Wells; Ur Metser; Michael Crump; David Hodgson; John Kuruvilla
Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada

现实世界比较：CAR T细胞疗法与历史标准治疗方案在安大略省加拿大治疗复发难治性大B细胞淋巴瘤患者中的医疗成本和资源利用比较：一项成本后果分析

BLOOD
IF23.1
2024-11-050
PRE
Kordbacheh, Tiana; Prica, Anca; Chan, Kelvin K. W.; Aminilari, Mahmood; Ante, Zharmaine; Liu, Ning; Gong, Inna Y.; Bhella, Sita D.; Crump, Michael; Vijenthira, Abi; Kuruvilla, John; Kridel, Robert; Chen, Christine, I; Kukreti, Vishal; Yang, Chloe; Malik, Nauman; Hodgson, David; Rodin, Danielle
A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada

加拿大安大略省复发/难治性大B细胞淋巴瘤的真实世界比较：CAR T细胞疗法与历史标准治疗方法的对比

BLOOD
IF23.1
2024-11-050
PRE
Kordbacheh, Tiana; Prica, Anca; Chan, Kelvin K. W.; Aminilari, Mahmood; Ante, Zharmaine; Liu, Ning; Gong, Inna Y.; Bhella, Sita; Crump, Michael; Vijenthira, Abi; Kuruvilla, John; Kridel, Robert; Chen, Christine, I; Kukreti, Vishal; Yang, Chloe; Malik, Nauman; Hodgson, David; Rodin, Danielle

研究方向

暂未获取到该数据
A
Andrew T. Yan
H 指数:54论文数:503被引数:1.2万
K
Kelvin Chan
H 指数:60论文数:603被引数:1.3万
D
Danielle Rodin
H 指数:26论文数:233被引数:3,845
M
Matthew C. Cheung
H 指数:36论文数:414被引数:5,383
A
Abi Vijenthira
H 指数:16论文数:111被引数:1,493
J
John Kuruvilla
H 指数:47论文数:636被引数:1.4万
R
Richard B. Kim
H 指数:84论文数:365被引数:2.7万
M
Michael Crump
H 指数:64论文数:584被引数:1.7万
R
Rena M. Conti
H 指数:40论文数:318被引数:8,083
M
Meredith B. Rosenthal
H 指数:52论文数:296被引数:1.2万